Publication: Incidence, Persistence, and Factors Associated With HPV Infection Among Male Adolescents With and Without Perinatally Acquired HIV Infection
2
Issued Date
2020-12-15
Resource Type
ISSN
19447884
Other identifier(s)
2-s2.0-85096152362
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of acquired immune deficiency syndromes (1999). Vol.85, No.5 (2020), 553-560
Suggested Citation
Sivaporn Gatechompol, Nipat Teeratakulpisarn, Orasri Wittawatmongkol, Sirinya Teeraananchai, Stephen J. Kerr, Amphan Chalermchockcharoenkit, Manopchai Thamkhantho, Thida Singtoroj, Nittaya Phanuphak, Annette H. Sohn, Kulkanya Chokephaibulkit Incidence, Persistence, and Factors Associated With HPV Infection Among Male Adolescents With and Without Perinatally Acquired HIV Infection. Journal of acquired immune deficiency syndromes (1999). Vol.85, No.5 (2020), 553-560. doi:10.1097/QAI.0000000000002499 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/60510
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Incidence, Persistence, and Factors Associated With HPV Infection Among Male Adolescents With and Without Perinatally Acquired HIV Infection
Abstract
BACKGROUND: Infection with high-risk human papillomavirus (HR-HPV) has been shown to be more prevalent and persistent in female adolescents with HIV. However, data among male adolescents with perinatally acquired HIV (PHIV) are limited. SETTING: We investigated the incidence and persistence of HR-HPV in anogenital compartments and associated factors among PHIV in comparison to HIV-uninfected (HU) male adolescents in Thailand. METHODS: PHIV and HU males aged 12-24 years were enrolled. At baseline and 3 subsequent annual visits, specimens from the scrotum, penis, and anal area were obtained for HPV and other testing. RESULTS: From June 2013 to October 2017, 49 PHIV and 47 HU male adolescents with a median age of 18 (interquartile range 17-20) years were enrolled. PHIV had higher incidence of any HR-HPV infection than HU adolescents {33.05 [95% confidence interval (CI): 20.82 to 52.46] vs. 15.73 [95% CI: 8.18 to 30.22] per 100 person-years, P = 0.04}. The persistence of any HR-HPV genotypes (detected at ≥2 annual visits) was not different by group (PHIV 27% vs. HU 23%, P = 0.75). Having ≥3 sex partners in past 6 months (adjusted prevalence ratio 2.39, 95% CI: 1.14 to 5.05; P = 0.02) and co-infection with other sexually transmitted infections (syphilis, chlamydia, and/or gonorrhea) were associated with persistent HR-HPV infection (adjusted prevalence ratio 6.21, 95% CI: 2.87 to 13.41; P < 0.001). CONCLUSIONS: Thai PHIV male adolescents had a higher incidence of HR-HPV infection than those without HIV. Having multiple sex partners and co-infection with sexually transmitted infections was associated with persistent HR-HPV infection. These data demonstrate the need to prioritize PHIV male adolescents in routine and catch-up HPV vaccination programs.